FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer. (2020)
Attributed to:
Confidence in Concept 2012 - Queen's University Belfast
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-019-0649-5
PubMed Identifier: 31772325
Publication URI: http://europepmc.org/abstract/MED/31772325
Type: Journal Article/Review
Volume: 122
Parent Publication: British journal of cancer
Issue: 3
ISSN: 0007-0920